（一）审议通过《关于续聘中兴财光华会计师事务所（特殊普通合伙）的议 案》 证券代码：300152 证券简称：新动力 公告编号：2024-068 雄安新动力科技股份有限公司 第五届监事会第十九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 雄安新动力科技股份有限公司(以下简称"公司或新动力")第五届监事会 第十九次会议通知于 2024 年 12 月 18 日以电话、短信、电子邮件等方式向公司 全体监事发出。会议于 2024 年 12 月 20 日在公司会议室以通讯方式召开。本次 会议应参会监事 3 名，实际参会监事 3 名。本次会议由公司监事会主席毛闯先 生召集并主持。本次会议的召集、召开及表决程序符合有关法律、行政法规、 部门规章、规范性文件及《公司章程》的规定。 二、监事会会议审议情况 中兴财光华会计师事务所（特殊普通合伙）作为公司 2023 年度审计机 构，在执业过程中坚持独立审计原则，能按时为公司出具各项专业报告，报告 内容客观、公正。综合考虑该所的审计质量与服务水平及收费情况，公司监事 会同意公司拟续聘中兴财光华 ...

Group 1 - The European economy is losing momentum, with manufacturing shrinking and service sector growth slowing down, leading to reduced investment spending by companies [1][3] - The European Central Bank (ECB) projects a 0.7% growth for the Eurozone in 2024, with an average inflation rate of 2.4% [1] - The economic growth drivers are shifting, with the service sector becoming a key contributor, particularly in countries like Greece and Spain benefiting from a rebound in tourism [1] Group 2 - Economic divergence is becoming more pronounced across regions, with developed economies expected to grow by 1.0% and Central, Eastern, and Southeastern Europe (CESEE) by 2.3% in 2024 [2] - Major industrial countries, particularly Germany and France, are showing concerning economic performance, with Germany's industrial output being the weakest among developed nations [2][3] Group 3 - The manufacturing sector is struggling, with the Eurozone's manufacturing Purchasing Managers' Index (PMI) declining from 46 to 45.2, and a significant rise in corporate bankruptcies [3] - High interest rates are limiting both consumer spending and private investment, with household savings rates reaching 14.8% in Q2, above pre-pandemic averages [3] Group 4 - Productivity stagnation is causing long-term economic challenges, with European tech productivity nearly flat since 2005, while the U.S. has seen a 40% increase [4] - The lack of venture capital and new company market share compared to the U.S. is contributing to a lack of business dynamism in Europe [4] Group 5 - The EU is attempting to enhance competitiveness through interest rate cuts, with new loan rates dropping to 4.7% in October, and a 1.2% year-on-year increase in bank loans to businesses [5] - A significant investment of €750 billion to €800 billion annually is needed for technology innovation and green energy to reverse the economic downturn [6] Group 6 - The EU is accelerating integration by removing border controls for Romania and Bulgaria, which is expected to enhance trade and investment opportunities [6] - A new free trade agreement with the Southern Common Market (Mercosur) is anticipated to provide substantial economic benefits to over 60,000 European companies [6] Group 7 - The European economy faces uncertainties from geopolitical risks, energy supply vulnerabilities, and rising sovereign debt risks threatening financial stability [7] - Natural disasters have caused significant economic losses, averaging €26 billion annually over the past decade, with potential future losses reaching up to €1.75 trillion [7] Group 8 - The euro's potential depreciation against the dollar is a concern, driven by weak Eurozone economic performance and strong dollar trends, which could increase inflationary pressures [8]

Summary of Conference Call on the Pharmaceutical Industry Industry Overview - The discussion primarily revolves around the pharmaceutical industry, particularly focusing on innovative drugs and medical devices [2][12][15]. Key Points and Arguments 1. **Innovation in Pharmaceuticals**: The industry is experiencing significant innovation, especially in high-end biopharmaceuticals, with a focus on addressing chronic diseases such as cardiovascular and respiratory diseases [2][12]. 2. **Drug Development Stages**: The process of developing innovative drugs involves multiple stages, including preclinical studies, clinical trials (phases I, II, and III), and post-market surveillance [4][5]. 3. **Challenges in Drug Development**: Companies face numerous challenges, including funding issues and high failure rates at various stages of drug development. The risk is inherent and often unavoidable [5][6]. 4. **Market Dynamics**: The oncology market is highlighted as a significant area, with the market size for oncology drugs in the U.S. being comparable to that of immunology drugs, approximately $1.3 billion [12]. 5. **Regulatory Environment**: Recent changes in the regulatory landscape, including the National Medical Insurance Bureau's support for innovative drugs, are expected to stabilize pricing and encourage innovation [18][19]. 6. **Investment Opportunities**: The pharmaceutical sector is viewed as a stable growth area, with a focus on innovative drugs and medical devices. The demand for healthcare solutions is expected to rise due to an aging population [27][28]. 7. **Market Valuation**: The current valuation of the pharmaceutical industry is considered low compared to historical levels, presenting potential investment opportunities [23][27]. 8. **Chronic Disease Management**: There is a growing emphasis on chronic disease management, with a significant patient population in need of innovative treatments [14][15]. 9. **Consumer Healthcare**: The consumer healthcare segment, including medical services and health management, is also identified as a growing area within the pharmaceutical industry [20][21]. Additional Important Insights - **Patient-Centric Approach**: The industry is shifting towards a patient-centric model, focusing on safety, efficacy, and convenience in drug delivery methods [10][11]. - **Long-Term Demand**: The pharmaceutical industry is characterized by stable long-term demand, driven by the necessity for healthcare solutions [26][27]. - **Investment Sentiment**: Despite recent market fluctuations, there is a renewed interest in increasing allocations to the pharmaceutical sector among institutional investors [24][25]. This summary encapsulates the key discussions and insights from the conference call regarding the pharmaceutical industry, highlighting its current state, challenges, and future opportunities for investment.

证券代码：300152 证券简称：新动力 公告编号：2024-066 雄安新动力科技股份有限公司 关于变更证券事务代表的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 雄安新动力科技股份有限公司（以下简称"公司"）原证券事务代表艾晨女 士因内部工作调整，不再担任公司证券事务代表职务，调整后仍在公司担任其他 职务。艾晨女士在担任证券事务代表期间，勤勉尽责、恪尽职守，认真履行职责， 为公司发展做出了积极贡献，公司及董事会对其在任职期间为公司所做出的贡献 表示衷心的感谢！ 公司于 2024 年 12 月 6 日召开了第五届董事会第三十二次会议，审议通过 了 《关于变更证券事务代表的议案》，同意聘任张平女士（简历详见附件）为 公司证券事务代表，协助董事会秘书开展工作，任期自本次董事会审议通过之日 起至公司第五届董事会届满之日止。 张平女士已经取得了深圳证券交易所颁发的董事会秘书资格证书，具备相关 的履职能力，其任职资格符合《中华人民共和国公司法》《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等相 ...

证券代码：300152 证券简称：新动力 公告编号：2024-065 （一）《关于变更证券事务代表的议案》 经审议，董事会同意聘任张平女士为公司证券事务代表，协助董事会秘书开 展工作，任期自本次董事会审议通过之日起至公司第五届董事会届满之日止。 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的相关公 告。 表决结果：同意 7 票；反对 0 票；弃权 0 票 雄安新动力科技股份有限公司 第五届董事会第三十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 雄安新动力科技股份有限公司(以下简称"公司或新动力")于 2024 年 12 月 6 日（星期五）在公司会议室以通讯方式召开了第五届董事会第三十二次会议。 本次会议通知已于 2024 年 12 月 3 日以电话、短信、电子邮件等方式向公司全体 董事发出。 本次会议由董事长程芳芳女士召集并主持，本次会议应出席董事 7 人，实际 出席董事 7 人，公司全体监事、高级管理人员列席了本次会议。本次会议的召集、 通知、召开和表决程序均符合《公司法》等有关法 ...

Group 1: Mergers and Acquisitions as a Tool for Economic Transformation - Mergers and acquisitions (M&A) are crucial market tools for supporting economic transformation and achieving high-quality development [1] - Companies in the Shanghai market are actively engaging in industrial integration, focusing on key sectors such as energy, military, pharmaceuticals, and electronics [1] - The integration of resources through M&A has led to significant improvements in operational efficiency and management flexibility among listed companies [1] Group 2: Industry-Specific M&A Examples - Haohua Technology's acquisition of 100% equity in Sinochem Lantian enhances the domestic fluorine materials supply chain and is a significant asset restructuring within Sinochem Group [2] - The merger is expected to improve profitability, with projected net profits for Haohua Technology reaching 1.235 billion yuan, 1.752 billion yuan, and 1.825 billion yuan from 2024 to 2026 [2] - AVIC's acquisition of Changhe Aircraft and Harbin Aircraft integrates helicopter manufacturing, enhancing business completeness and reducing related transactions [3] Group 3: New Quality Productivity and Strategic Focus - M&A is driving the development of new quality productivity, particularly in areas supported by national strategies such as import substitution and supply chain security [3] - Companies are focusing on technology innovation and resource integration through M&A to create high-quality enterprises with strong leadership [3] Group 4: Diversification and Strategic Acquisitions - Puyuan Precision's acquisition of Nais Electronics aims to enhance R&D capabilities and meet customer demands in specialized equipment for advanced technology fields [4] - Anfu Technology's transition from traditional retail to the battery industry through acquisitions has led to a turnaround in profitability and a strong market position [4] Group 5: Global Expansion through Overseas Acquisitions - Companies are increasingly looking to expand globally, with Wenta Technology's acquisition of Anshi Semiconductor marking a significant cross-border M&A in the semiconductor industry [5] - Haier's acquisition of GE Appliances for approximately $5.4 billion has positioned it as a leader in the global home appliance market, with steady revenue and profit growth over eight years [5] Group 6: Innovative Financing Methods in M&A - Companies are encouraged to use a combination of shares, cash, and convertible bonds for M&A, facilitating smoother transactions [6] - Sirepo's acquisition of Chuangxin Microelectronics using convertible bonds is a notable case of innovative financing in M&A [6] Group 7: Asset Restructuring and Market Positioning - Qilian Mountain's asset swap with China Communications Construction Company aims to reduce share dilution and enhance market valuation [7] - The restructuring is expected to improve the overall valuation of China Communications Construction by addressing competition issues within the group [7]

Core Viewpoint - The launch of the new Volkswagen Tayron L marks a significant step for FAW-Volkswagen in enhancing its SUV market presence and adapting to evolving consumer demands [1][2][3] Group 1: Production and Investment - FAW-Volkswagen has invested 2 billion yuan in upgrading the production line for the new Tayron L [2] - The Tayron model has regained the top position in its market segment since September, with cumulative sales exceeding 130,000 units [2] - Since its launch in October 2018, the Tayron has achieved cumulative sales of over 850,000 units [2] Group 2: Product Features and Design - The Tayron L features two front-end styles, offering a modern and sporty aesthetic with enhanced visual appeal [3][4] - The vehicle's dimensions include a wheelbase of 2791mm, providing improved headroom and legroom compared to the current model [4] - The Tayron L is equipped with a three-screen interactive system, enhancing user experience with advanced connectivity and voice interaction capabilities [4][5] Group 3: Advanced Technology - The Tayron L incorporates the IQ. Pilot system, a Level 2+ driving assistance technology tailored for complex Chinese road conditions [5] - Additional features include a heads-up display (HUD) that projects critical driving information onto the windshield, improving safety [4][5]

证券代码：300152 证券简称：新动力 公告编号：2024-064 雄安新动力科技股份有限公司 关于公司股票交易异常波动暨严重异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股票交异常波动的情况介绍 雄安新动力科技股份有限公司（以下简称"新动力"或"公司"）2024 年 10 月 29 日、10 月 30 日、10 月 31 日连续 3 个交易日收盘价格涨幅偏离值累计 超过 30%，根据深圳证券交易所的有关规定，属于股票交易异常波动的情况。同 时，公司股票交易于 2024 年 10 月 24 日至 2024 年 10 月 31 日连续 6 个交易日收 盘价格涨幅偏离值累计超过 100%，根据《深圳证券交易所交易规则》的有关规 定，属于股票交易严重异常波动的情形。 二、公司关注并核实情况 针对公司股票交易异常波动暨严重异常波动的情况，公司董事会通过电话及 书面问询等方式，对公司、公司第一大表决权股东天津腾宇高通信息咨询合伙企 业（有限合伙）及其一致行动人就相关事项进行了核实，现将有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充 ...

一致行动人:南昌达亿投资有限公司 雄安新动力科技股份有限公司 详式权益变动报告书 上市公司:雄安新动力科技股份有限公司 股票上市地点:深圳证券交易所 股票简称:新动力 股票代码: 300152 信息披露义务人:天津腾宇高通信息咨询合伙企业(有限合伙) 通讯地址:天津自贸试验区(空港经济区)西三道 158 号 5 幢 902-B (天津信至 嘉商务秘书有限公司托管第 800 号） 通讯地址:江西省南昌市安义县新经济产业园内 一致行动人:方海云 通讯地址:北京市海淀区光大花园 股份变动性质:不涉及持股数量的增减,因签署一致行动人协议而履行信息披露 义务 二零二四年十月 雄安新动力科技股份有限公司 详式权益变动报告书 信息披露义务人声明 一、本报告书系依据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司收购管理办法》和《公开发行证券的公司信息披露内容与格式准则第 15 号-权益变动报告书》、《公开发行证券的公司信息披露内容与格式准则第16 号―上市公司收购报告书》等相关法律、法规和规范性文件编写。 二、依据《中华人民共和国证券法》《上市公司收购管理办法》的规定,本 报告书已全面披露了信息披露义务人在雄安 ...

Financial Performance - Revenue for the reporting period reached RMB 86,326,118.38, a year-on-year increase of 152.72%[3] - Net profit attributable to shareholders of the listed company for the reporting period was RMB 5,391,279.52, up 128.21% year-on-year[3] - Revenue for the current period reached 189,099,266.49, a 33.2% increase compared to the previous period's 141,965,901.61[16] - Net profit for the current period was -1,904,911.23, an improvement from the previous period's -24,469,490.22[17] - Total comprehensive income for the current period was -1,904,911.23, compared to -27,559,490.22 in the previous period[17] - Basic earnings per share improved to -0.0027 from -0.0343 in the previous period[17] Cash Flow and Liquidity - Operating cash flow for the period from the beginning of the year to the end of the reporting period was RMB 19,467,910.61, a significant increase of 220.14% year-on-year[3] - Net cash flow from operating activities was 19,467,910.61, a significant increase from the previous period's 6,080,980.98[18] - Cash received from other operating activities increased to 32,110,216.51, up from 25,260,774.29 in the previous period[18] - Cash paid for goods and services increased to 39,265,300.11, a 54.8% rise from the previous period's 25,364,307.78[18] - Cash received from borrowings amounted to 61,890,000.00[19] - Cash used for debt repayment was 65,057,288.01[19] - Cash used for dividend, profit, or interest payment was 861,096.23[19] - Net cash flow from financing activities was -10,774,131.74[19] - Net increase in cash and cash equivalents was -5,080,787.76[19] - Ending balance of cash and cash equivalents was 1,844,301.56[19] - The company's cash and cash equivalents decreased from 12,407,863.12 yuan at the beginning of the year to 5,723,051.70 yuan as of September 30, 2024[13] Assets and Liabilities - Total assets as of the end of the reporting period were RMB 801,592,907.99, a slight increase of 0.56% compared to the end of the previous year[3] - The company's total assets as of September 30, 2024, amounted to 801,592,907.99 yuan, with a slight increase from the beginning of the year[13][14] - The company's total liabilities as of September 30, 2024, were 480,111,289.70 yuan, showing a minor increase compared to the start of the year[14] - The company's equity attributable to the parent company was 321,483,442.40 yuan, with a slight decrease from the beginning of the year[14] - The company's total equity as of September 30, 2024, was 321,481,618.29 yuan, with a slight decrease from the beginning of the year[15] - The company's accounts receivable increased slightly from 104,167,985.64 yuan at the beginning of the year to 104,585,893.42 yuan as of September 30, 2024[13] - The company's inventory remained relatively stable, with a slight increase from 189,890,011.73 yuan at the beginning of the year to 189,967,600.17 yuan as of September 30, 2024[13] - The company's long-term equity investments remained unchanged at 35,490,656.96 yuan from the beginning of the year to September 30, 2024[13] - The company's fixed assets decreased from 110,691,474.63 yuan at the beginning of the year to 102,886,870.07 yuan as of September 30, 2024[13] - The company's intangible assets decreased slightly from 91,547,021.06 yuan at the beginning of the year to 89,337,125.96 yuan as of September 30, 2024[13] Shareholders and Equity - Total number of ordinary shareholders at the end of the reporting period: 57,310[7] - Top shareholder: Jin Yuan Securities Co., Ltd., holding 4.30% of shares, totaling 30,620,000 shares[7] - Second largest shareholder: Qingdao Juntu Investment Consulting Management Partnership, holding 4.21% of shares, totaling 30,000,000 shares[7] - Third largest shareholder: Tianjin Tengyu Gaotong Information Consulting Partnership, holding 2.53% of shares, totaling 18,000,000 shares[7] - Fourth largest shareholder: Nanchang Dayi Investment Co., Ltd., holding 1.68% of shares, totaling 12,000,000 shares[7] - Fifth largest shareholder: Fang Haiyun, holding 1.66% of shares, totaling 11,797,400 shares[7] - Sixth largest shareholder: Zhang Shengmao, holding 0.58% of shares, totaling 4,157,471 shares[7] - Seventh largest shareholder: Morgan Stanley & Co. International PLC, holding 0.55% of shares, totaling 3,900,807 shares[7] - Eighth largest shareholder: Huatai Securities Co., Ltd., holding 0.53% of shares, totaling 3,770,800 shares[7] - Ninth largest shareholder: Xu Bing, holding 0.48% of shares, totaling 3,400,000 shares[7] Operating Costs and Expenses - Operating costs for the current period were 201,629,747.42, an 18.5% increase from the previous period's 170,062,284.36[16] - Research and development expenses increased to 6,077,840.93, up 10.9% from the previous period's 5,481,850.42[16] - Sales revenue from goods and services was 100,995,609.02, a slight decrease from the previous period's 105,872,811.49[18] Government Subsidies and Other Income - Government subsidies received during the reporting period amounted to RMB 203,250.64[4] Asset and Credit Impairment - Credit impairment losses rose by 64.38% to RMB 9,712,987.37, driven by increased bad debt provisions[6] - Asset impairment losses decreased by 91.06% to RMB 43,923.61, mainly due to the reversal of asset impairment[6] Prepayments and Receivables - Prepayments increased by 42.76% to RMB 16,022,265.75 due to advance payments for procurement in ongoing projects[6] - Other receivables surged by 194.78% to RMB 20,581,196.81, primarily due to increased project bid deposits[6] - Contract assets grew by 94.23% to RMB 38,166,174.35, mainly due to increased warranty deposits for settled projects[6] Audit and Reporting - The company's Q3 report was unaudited[19]